Komori
Daito Pharmaceutical (4577) · RiskDropped

Higher corporate costs due to labor shortages and rising utility expenses

First written in FY2018. 1 of 2 entries say "Dropped", first in FY2019. Latest entry: FY2019.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018 – FY20192018: 120182019: 12019
Same theme, other companies
Supply constraints and rising costs for materials, power and construction resourcesA theme 21 companies write about · 21 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2017: 3 of 9 companies on the "Worse" side.

0 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.
Higher corporate costs due to labor shortages and rising utility expenses | Daito Pharmaceutical Co.,Ltd. (4577) | Komori